John Walker

Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial

Alexander Eggermont, Christian U. Blank, Mario Mandalà et al. · The Lancet Oncology · 2021 · 364 citations · Full text

Surgical Oncology, Medicine, Melanoma +8

Somatic mutation of vascular endothelial growth factor receptors in juvenile hemangioma

Jeffrey W. Walter, Paula E. North, Milton Waner et al. · Genes Chromosomes and Cancer · 2001 · 211 citations

Vascular Malformation, Pathology, Juvenile Hemangiomas +17

Bioproduction of Conjugated Linoleic Acid by Probiotic Bacteria Occurs In Vitro and In Vivo in Mice

Julia B. Ewaschuk, John Walker, Hugo Díaz et al. · Journal of Nutrition · 2006 · 203 citations

Probiotic, Biochemistry, In Vitro Fermentation +7

Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial

Jean‐Pascal Machiels, Yungan Tao, Lisa Licitra et al. · The Lancet Oncology · 2024 · 174 citations · Full text

Concurrent Chemoradiotherapy, Neoadjuvant Therapy, Squamous Cell Carcinoma +6

Citrobacter rodentium infection causes both mitochondrial dysfunction and intestinal epithelial barrier disruption in vivo: role of mitochondrial associated protein (Map)

Caixia Ma, Mark E. Wickham, Julian A. Guttman et al. · Cellular Microbiology · 2006 · 145 citations · Full text

E. Coli, Electron Microscopy, Mitochondrial Function +13